The present report is the first clinical evaluation of a new sensitive and specific immunoassay (enzyme-linked immunosorbent assay, ELISA) for determination of thymidine kinase 1 in serum from breast cancer patients. The gene discussed is TK1; the disease is breast carcinoma.